Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
genentech
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
cancer
eli lilly
indiana blog main
indiana top stories
roche
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer drugs
clinical trials
deals
detroit blog main
detroit top stories
fda
loxo oncology
medullary thyroid cancer
national
new york blog main
new york top stories
non-small cell lung cancer
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
selpercatinib
What
cancer
4
×
approval
blueprint
drug
fda
medicines
ret
address
annual
appetite
approves
bio
black
bread
breast
butter
buyout
cancer's
candidate
carries
cash
certain
clinical
conference
currently
data
designed
diabetes
diamond’s
drugs
eli
esmo
european
genetic
giant
grabbed
hasn’t
hold
latest
lilly's
Language
unset
Current search:
genentech
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
